Market News AIOpen the app

B. Riley has cut its price target for Microbot Medical to $3 from $4 but still thinks it's a good buy.

OpinionRead the original at marketscreener.com
Neutral

B. Riley lowered its target for Microbot from $4 to $3 but kept its Buy rating.

MBOT · Microbot Medical Inc.

AI read · Neutral

The AI's read

This is one firm's view, not a new report from Microbot about its business. The lower target points to a weaker view of the shares, but keeping Buy still favors them. Those views pull in opposite directions, so this update alone does not change what is known about the company.

Get alerts for MBOT

Follow Microbot Medical Inc. (MBOT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for MBOT
Free on the App Store and Google Play, or on the web.